Faculty Focus: Publications: Eisermann, K

Kurtis Eisermann, Ph,D

Assistant Professor

Dar, J. A., Masoodi, K. Z., Eisermann, K., Isharwal, S., Ai, J., Pascal, L. E., Nelson, J. B., and Wang, Z. The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells. J Steroid Biochem Mol Biol. 2014 Sep; 143:473-80. doi: 10.1016/j.jsbmb.2014.03.004.

O’Malley, K. J., Eisermann, K. (co-first author), Pascal, L. E., Graham, L., Hrebinko, K., Stewart, N. A., Acquafondata, M., Nelson, J. B., Parwani, A., and Wang, Z. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia. The Prostate. 2014 Jun; 74(8):892-900. doi: 10.1002/pros.22807.

Eisermann, K., Dar, J. A., Dong, J., Wang, D., Masoodi, K. Z., and Wang, Z. Poly (A) binding protein cytoplasmic 1 is a novel co-regulator of the androgen receptor. PLoS One. 2015 Jul 15; 10(7):e0128495. doi: 10.1371/journal.pone.0128495.

Johnson, J. K., Skoda, E. M., Zhou, J., Parrinello, E., Wang, D., O’Malley, K., Eyer, B. R., Kazancioglu, M., Eisermann, K., Johnston, P. A., Nelson, J. B., Wang, Z., and Wipf, P. Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer. ACS Medicinal Chemistry Letters. 2016 May; doi: 10.1021/acsmedchemlett.6b00186.

Eisermann, K. and Fraizer, G.C. The androgen receptor and VEGF: mechanisms of androgen regulated angiogenesis in prostate cancer. Cancers. (Basel). 2017 Apr 10;9(4). pii: E32. doi: 10.3390/cancers9040032.

Masoodi, K.Z., Xu, Y., Dar, J.A., Eisermann, K., Pascal, L.E., Parrinello, E., Ai J., Johnston, P.A., Nelson, J.B., Wipf, P., and Wang, Z. Inhibition of Androgen Receptor Nuclear Localization and Castration Resistant Prostate Tumor Growth by Pyrroloimidazole-Based Small Molecules. Mol Cancer Ther. 2017 Jun 27. pii: molcanther.0176.2017. doi: 10.1158/1535-7163.MCT-17-0176.

Masoodi, K.Z., Eisermann, K. (co-first author), Yang, Z., Dar, J.A., Pascal, L.E., Nguyen, M., O’Malley, K., Parrinello, E., Feturi, F.G., Kenefake, A.N., Nelson, J.B., Johnston, P.A., Wipf, P., and Wang, Z. Inhibition of androgen receptor function and level in castration-resistant prostate cancer cells by 2-((isoxazol-4-ylmethyl)thio)-1-(4-phenylpiperazin-1-yl)ethanone. Endocrinology. 2017 July 24. https://doi.org/10.1210/en.2017-00408.

Book chapter

Fraizer, G. C., Eisermann, K., Pandey, S., Brett-Morris, A., Nock, S., Ghimirey, N., Kuerbitz, S. J. Functional Role of WT1 in prostate cancer. In: van den Heuvel-Eibrink MM, editor. Wilms Tumor [Internet]. Brisbane (AU): Codon Publications; 2016 Mar. Chapter 14.